Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 2 Goates et al.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Medical cannabis costs family £4,000 a month to help teenager. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Cannigma

OCTOBER 14, 2022

Recreational cannabis is not legal, despite a 2019 citizen’s initiative that called for legalization. In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. Can you bring or buy cannabis products?

Law 56

Law Clinical Trials Research and Development Recreational 56

Cannabis Law Report

AUGUST 5, 2021

Although the overarching market is still relatively new, much like the cannabis boom a few years ago the psychedelics space is growing at an unprecedented rate. billion in 2019. Over the next several years, the psychedelics industry is expected to grow at a compound annual growth rate of 16.3 per cent to reach US$6.86

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Benefits of the Transaction. The Transaction.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

The Cannigma

JANUARY 24, 2021

This article was first published on Analytical Cannabis. The next weapon against antibiotic-resistant bacteria could lie within the cannabis plant, according to a new study. It appears here with permission. A future drug? The post CBD Can Kill Antibiotic-Resistant Gonorrhea Bacteria, Study Finds appeared first on The Cannigma.

CBD 125

CBD Clinical Trials Treatment Pharmaceutical 125

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. The development has been welcomed and comes as the nation’s doctors are said to be shifting their cultural stance from viewing ‘cannabis as a dirty word’.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

SEPTEMBER 20, 2019

17, 2019 /PRNewswire/ — PRESS RELEASE — GB Sciences, Inc. 13, 2019, filed an 8k announcing the sale of its 50-percent ownership stake in GB Sciences Louisiana, LLC. LAS VEGAS, Sept. on Friday, Sep. Source: [link].

Clinical Trials 40

Clinical Trials Research and Development DEA Business 40

Veriheal

FEBRUARY 11, 2021

Cannabis and opioid medications both produce analgesic effects. Researchers who recently published a survey they conducted, wanted to see whether medical cannabis has an effect on the usage of or even possibly replace opioid medications. The Effect of Medical Cannabis on Prescription Opioids. America’s Cannabis Catch-22.

Chronic Pain 69

Chronic Pain Patients Clinical Trials Treatment 69

Cannabis Law Report

DECEMBER 14, 2019

Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. million in the Melbourne cannabis firm in 2018. Writes Investing News.com.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

NOVEMBER 1, 2021

Traces of banned drugs have been found in nearly 200 imported cannabis-derived wellness products that have been gaining popularity in Hong Kong in recent years, a customs source has told the Post. The substance is allowed in Hong Kong as long as other prohibited ingredients derived from cannabis are not present in the products.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

The Cannigma

MARCH 7, 2022

Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

The Cannigma

SEPTEMBER 21, 2021

In the world of cannabis, not everyone can be Snoop, Seth Rogen, or Willie Nelson. There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. I also take a chewy (cannabis pill) at bedtime and this has really helped, too.”. 1) Patrick Stewart. 3) Steve Kerr.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Cannabis for GI Pathologies . A clinical study done by Steele Clark Smith and Mark Wagner found that cannabis consumption led to improved IBS symptoms as a whole. What is IBD?

Digestion 120

Digestion Treatment Conditions Research and Development 120

Cannabis Law Report

JUNE 25, 2021

Major players in the global skin cancer drugs market are Novartis AG, Bristol Myers Squibb, Eli Lilly, Meda, and Sun Pharmaceutical Industries Ltd. In April 2019, Bristol-Myers Squibb acquired Celgene for $74 billion. According to the American Academy Of Dermatology, 192,310 new cases of Melanoma type skin cancer were expected in 2019.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Veriheal

MARCH 23, 2023

One of the proposed bills would amend the Cannabis Control Law during the current 150-day Diet session, which launched on Monday, January 23. Based on Japan’s Cannabis Control Law—A.K.A. Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products.

Legalization 58

Legalization Marijuana Clinical Trials Seed-To-Sale 58

CannaTech

JANUARY 27, 2019

Capitalizing on cannabis is occurring across the Western hemisphere. However, by counting on one plant, such as cannabis, it is simple to reach millions of people and capitalize on billions of dollars, pesos, sol (Peruvian currency), or real (Brazilian currency). After all, cannabis is a cash crop. land, labs, licenses).

Clinical Trials 81

Clinical Trials Cultivation Research and Development Cannabis 81

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Veterans can expect to find conflicting information regarding the efficacy of cannabis for their PTSD.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

DECEMBER 7, 2021

06, 2021 (GLOBE NEWSWIRE) — South Africa’s Cannabis Holdings Group Labat Africa Limited, has listed its shares as a dual listing on the Frankfurt Stock Exchange (FSE). It comes off the back of Germany’s new coalition government planning to legalize cannabis for medicinal and recreational purposes.

Clinical Trials 52

Clinical Trials Medicine Cannabis Pharmaceutical 52

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. This disconnect is commonly referred to as the placebo effect.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). The rollercoaster starts here!

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 12, 2019), [link] [ [link] ]. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. Mitchell et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

SEPTEMBER 3, 2019

Awarded Australian Cannabis Industry 2019 Innovation Award. 03, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. We are delighted to start working with this Licensed Producer, and others, who share our vision of providing the highest quality pharmaceutical-grade products. Further Strengthens Australian Leadership Team.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

JULY 9, 2021

Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. Denver, Colorado was the first jurisdiction to decriminalize the use of psilocybin via ballot initiative in May 2019. 30, 2019), available at [link]. Id ; 21 CFR 312.1-10;

Law 105

Law Therapy Clinical Trials Research and Development 105

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization).

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

AUGUST 2, 2021

Radicle ACES findings will address the top two barriers to CBD usage identified in a 2019 Nielsen study : 1) difficulty gauging effectiveness of specific products, and 2) lack of research data on health benefits. Eric Schudiske, eric@s2spr.com.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

NOVEMBER 15, 2021

Although a limited number of CGTs are currently on the market, FDA officials predicted in 2019 that the agency will receive more than 200 investigational new drug applications per year for cell and gene therapies and that by 2025, it expects to have accelerated to 10 to 20 cell and gene therapy approvals per year 1. January 15, 2019.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

JULY 15, 2019

PUBLISHER: CANNABIS LAW REPORT. July 18 marks the first anniversary of the Portuguese medical cannabis law. The major merit of Decree Law 8/2019 was to provide a clear distinction between cannabis-based medicinal products, cannabis-based preparations and cannabis-based substances (dried flower and oils).

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

JULY 6, 2021

In 2019, Dr. Johnson received the R. Dr. Bankole Johnson was also the founder of NASDAQ listed Adial Pharmaceuticals (NASDAQ: ADIL) and currently serves as its Chief Medical Officer. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.”

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

APRIL 8, 2019

PUBLISHER: CANNABIS LAW REPORT. Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Josh Hunt – Partner. Callum Twigger – Lawyer.

Medicine 71

Medicine Research and Development Business Cannabis 71

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Knowing these can allow you or your healthcare provider to look up the metabolism of a pharmaceutical drug and determine if a CBD-drug interaction is possible. CBD and Glaucoma.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JULY 24, 2019

Marketwatch report… Shares of cannabis company Curaleaf Holdings Inc. July 22, 2019. On your Facebook Social Media Account: • April 8, 2019 posting – “CBD Can be a powerful ally if you’re suffering from chronic inflammation and pain.”. tumbled more than 7% Tuesday and dragged the broader sector lower, after the U.S.

CBD 51

CBD Tincture Pets Chronic Pain 51

Project CBD

OCTOBER 26, 2023

Adapted from The Cannabis Cancer Connection: How to use cannabis and hemp to kill cancer cells by Joe D. The vast majority of the existing research is on how specific cannabinoids kill cancer, but a growing body of work is revealing how the entourage of compounds found in whole-plant cannabis kills cancer.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

JANUARY 11, 2019

Thus, the law permits a wide range of dietary ingredients in dietary supplements, including CBDwhich is an extract of a botanical ( Cannabis sativa L. There is no evidence that CBD is liable to similar abuse and similar ill-effects as substances…such as cannabis or THC.” [7].

Hemp 49

Hemp CBD Law Seed-To-Sale 49